Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
New Therapies and Current Patient Management of Lymphomas
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
Immunotherapy for R/R Mantle Cell Lymphoma - ZUMA-2 Trial of KTE-X19
FEATURING
James Gerson
- 166 views
- February 21, 2020
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
ASH 2019 Updates on Large Cell Lymphoma: Use of ClonoSEQ in Diagnosis, PET-Directed Therapy in Limited-Stage DLBCL, Burkitt Lymphoma Treatment Options & MATRIX-RICE followed by ASCT for CNS Lymphoma
FEATURING
Sunita D. Nasta
- 41 views
- February 25, 2020
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
New Agents in R/R Large Cell Lymphoma: Pola + BR Promising Treatment, Blinatumomab and Lenalidomide Have Limited Efficacy, & Mosunetuzumab Monotherapy Achieves CR in High-Risk Pts
FEATURING
Sunita D. Nasta
- 96 views
- February 25, 2020